GLP-1 receptor agonists, including the blockbuster drugs semaglutide and tirzepatide, are increasingly being prescribed to patients with type 1 diabetes, despite having no FDA approval for this indication, according to a study published Wednesday in the Journal of the American Medical Association
Methionine S-adenosyl-methionine (SAM-e) is a supplement that contains methionine and can also help boost glutathione levels
*Ozempic and Mounjaro are primarily approved for type 2 diabetes in many countries, while Wegovy and Zepbound are specifically approved for chronic weight management
These medications are GLP-1 agonists, commonly used by patients with type 2 diabetes
Studies indicated that DSIP may protect neuronal cells from excitotoxicity and oxidative stress, making it a valuable compound for researchers investigating neuroprotection mechanisms
Brighter Skin:Promotes a more youthful, glowing complexion